Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 261-491-7 | CAS number: 58909-56-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://poisoncentres.echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1995
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: A study according to the OECD method, including GLP.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 995
- Report date:
- 1995
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- no
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- The LLNA-method was not available at the time of initiation the study.
Test material
- Reference substance name:
- (6R-trans)-7-amino-8-oxo-3-[[(1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-1,2,4-triazin-3-yl)thio]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- EC Number:
- 261-491-7
- EC Name:
- (6R-trans)-7-amino-8-oxo-3-[[(1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-1,2,4-triazin-3-yl)thio]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- Cas Number:
- 58909-56-1
- Molecular formula:
- C12H13N5O5S2
- IUPAC Name:
- 7-amino-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- Test material form:
- solid: particulate/powder
- Remarks:
- migrated information: powder
- Details on test material:
- Name: 7-ACT
Chemical name: (6R, 7R)-7-Amino-3-(2,5-dihydro-2-methyl-5-oxo-6-hydroxy-1,2,4-triazin-3-yl) thiomethyl-ceph-3-em-4-carbonic acid
CAS No.: 58909-56-1
Supplier: Biochemie Ges.m.b.H.
Batch No.: 3201530
Purity: 99.5 % (content related to waterfree substance)
Water content: 1.5 %
Impurities: Heavy metals: < 20 ppm, by-products: < 0.2 % each
Appearance: white powder
pH: 3.97 (1 % aqueous suspension, measured by pH-meter)
Stability of the test substance: stable under conditions of storage
Disintegration: from 180 *C on
Storage: in a refrigerator in the dark
Date of handing over: July 26, 1994
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Hartley
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Charles River Wiga. D-97633 Sulzfeld. Germany.
- Age at study initiation: 6 weeks.
- Weight at receipt: ca. 300 g.
- Housing: single caged.
- Diet: Altromin No. 3022, ad libitum
- Water: tap water, acidified with HCl to pH 3, ad libitum
- Acclimation period: ca. 2 weeks.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): average of ca. 22
- Humidity (%): average of ca. 45
- Air changes (per hr): 12
- Photoperiod (hrs dark / hrs light): 12/12
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal and epicutaneous
- Vehicle:
- petrolatum
- Concentration / amount:
- Negative control, induction, intradermal: 0.1 mL each of physiological saline; FCA/saline 1+1 v/v; and FCA/saline 1+1 v/v .
Negative control, induction, epicutaneous: 0.5 g white petrolatum.
Negative control, challenge, epicutaneous: 0.6 g of a 20 % test substance formulation in white petrolatum on the left side + 0.5 g white petrolatum on the right side.
Test substance group, induction, intradermal: 0.1 mL each of 5 % test substance in physiological saline, w/v; FCA/saline 1+1 v/v; and 5 % final test substance in a mixture of FCA/physiological saline 1 + 1, v/v). 500 mg of the test substance were suspended in 7.2 ml physiological saline. 2.8 ml of 1 m NaOH solution were then added drop by drop under stirring to obtain a solution.
Test substance group, induction, epicutaneous: 0.6 g of a 40 % test substance formulation in white petrolatum
Test substance group, challenge, epicutaneous: 0.6 g of a 20 % test substance formulation in white petrolatum on the left side + 0.5 g white petrolatum on the right side.
The test substance concentrations were based on the result of a preliminary experiment. At the concentration of 40 % in epicutaneous exposure 2/3 animals had very slight erythema 48 hours after the start of the exposure.
FCA: Freund's complete adjuvant (Difco Laboratories, Article No 0638-60-7).
Challengeopen allclose all
- Route:
- epicutaneous, occlusive
- Vehicle:
- petrolatum
- Concentration / amount:
- Negative control, induction, intradermal: 0.1 mL each of physiological saline; FCA/saline 1+1 v/v; and FCA/saline 1+1 v/v .
Negative control, induction, epicutaneous: 0.5 g white petrolatum.
Negative control, challenge, epicutaneous: 0.6 g of a 20 % test substance formulation in white petrolatum on the left side + 0.5 g white petrolatum on the right side.
Test substance group, induction, intradermal: 0.1 mL each of 5 % test substance in physiological saline, w/v; FCA/saline 1+1 v/v; and 5 % final test substance in a mixture of FCA/physiological saline 1 + 1, v/v). 500 mg of the test substance were suspended in 7.2 ml physiological saline. 2.8 ml of 1 m NaOH solution were then added drop by drop under stirring to obtain a solution.
Test substance group, induction, epicutaneous: 0.6 g of a 40 % test substance formulation in white petrolatum
Test substance group, challenge, epicutaneous: 0.6 g of a 20 % test substance formulation in white petrolatum on the left side + 0.5 g white petrolatum on the right side.
The test substance concentrations were based on the result of a preliminary experiment. At the concentration of 40 % in epicutaneous exposure 2/3 animals had very slight erythema 48 hours after the start of the exposure.
FCA: Freund's complete adjuvant (Difco Laboratories, Article No 0638-60-7).
- No. of animals per dose:
- 10 in the control group.
20 in the test substance group. - Details on study design:
- Hair was clipped on Days 0 and 21 on the treatment areas.
First induction exposure on Day 0: intradermal injections of the test substance, of FCA (to enhance a possible sensitisation) and of the test substance diluted with FCA. Application site was an area of approx. 2 cm x 4 cm in the interscapular region.
Second induction exposure on Day 7: epicutaneous application of the test substance to the sites of the intradermal injections for 48 hours.
Challenge exposure on Day 21 for 24 hours: epicutaneous application of the test substance to the left flanks and application of the vehicle to the right flanks of all animals.
Readings of skin reactions at 24 and 48 h after challenge, i.e. on Days 23 and 24. - Challenge controls:
- The method was checked periodically with 1,4-phenylenediamine
- Positive control substance(s):
- yes
Results and discussion
- Positive control results:
- Last positive control test:
Results after the challenge exposure:
The control areas of all animals were normal. There were no positive skin reactions at the 1,4-phenylenediamine treated sites of the negative control group. In the positive control group 5/5 animals, i.e. 100 %, had positive reactions on the 1,4 phenylenediamine treated sites 24 and 48 hours after the end of the challenge exposure and were regarded as sensitised.
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 20 % test substance
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 20 % test substance. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 20 % test substance
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 20 % test substance. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 20 % test substance
- No. with + reactions:
- 19
- Total no. in group:
- 20
- Clinical observations:
- Score 2 and 3 were observed. Eschar was recorded in 7 cases.
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 20 % test substance. No with. + reactions: 19.0. Total no. in groups: 20.0. Clinical observations: Score 2 and 3 were observed. Eschar was recorded in 7 cases..
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 20 % test substance
- No. with + reactions:
- 19
- Total no. in group:
- 20
- Clinical observations:
- Score 1 and 3 were observed. Eschar was recorded in 14 cases.
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 20 % test substance. No with. + reactions: 19.0. Total no. in groups: 20.0. Clinical observations: Score 1 and 3 were observed. Eschar was recorded in 14 cases..
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- positive control
- Dose level:
- 5 %
- No. with + reactions:
- 5
- Total no. in group:
- 5
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- positive control
- Dose level:
- 5 %
- No. with + reactions:
- 5
- Total no. in group:
- 5
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- other: negative control to the positive control
- Dose level:
- 5 %
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- other: negative control to the positive control
- Dose level:
- 5 %
- No. with + reactions:
- 0
- Total no. in group:
- 5
Any other information on results incl. tables
One animal of the negative control group died spontaneously on day 7. A post mortem examination did not reveal the cause of death. As since the start of this study one spare animal had been kept and administered under the same conditions as the other control animals, the deceased animal was replaced by the spare animal. The outcome of this study was not adversely affected by this event.
All other animals survived till the end of the study.
There were no significant differences in the mean body weights between the test substance group and the control group on Days 0 and 24. Immediately after the beginning of all epicutaneous exposures (induction, challenge) the motor activities of all animals were increased. This is due to the dressings which restrict the freedom of movement. Soon afterwards the behaviour was regular again. Except for this observations no abnormal behaviour or clinical signs were detected during the experiment.
Skin reactions:
Skin reactions after the intradermal induction exposure:
Cranial and caudal injection sites: Local irritations were observed in all animals beginning on the day after the injections. The irritations started with local erythema, which became more severe and led to ulcerations. This local alterations are known effects of Freund's adjuvant.
Middle injection sites: No irritant reactions were observed 24 hours after induction exposure in the negative control group, whereas very slight to well defined erythema were noted in 8/20 animals of the test substance group.
Skin reactions after the epicutaneous induction exposure:
All animals had severe erythema and oedema in the interscapular region, which were attributed to the effects of the adjuvant.
Skin reactions after the challenge exposure
These are the reactions of major interest for the grading of an allergenic potency of the test substance.
Negative control group:
Vehicle site: no positive skin reaction in any animal at any reading time.
Test substance site: no positive skin reaction in any animal at any reading time.
No animal had a "positive skin reaction".
Test substance group:
Vehicle site: A post mortem examination did not reveal the cause of death..
Test substance site: Very slight to severe erythema and/or oedema in 19/20 animals 24 and/or 48 hours after the end of the challenge exposure and, additionally, eschars in 14 of these animals at the first and/or second reading time.
19/20 animals had a "positive skin reaction", they are regarded as sensitised.
Applicant's summary and conclusion
- Interpretation of results:
- sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- 19/20 animals of the test substance group, i.e. 95 % of the animals, were regarded as sensitised.
- Executive summary:
The maximisation test of B. Magnusson and A. M. Kligman was performed according to the OECD-method 406 to detect a possible sensitising potential of 7 -ACT. 20 female guinea pigs were used as a test substance group and another 10 females as a negative control group. There were two induction exposures (intradermally and epicutaneously) and one epicutaneous challenge exposure. Test substance concentrations were:
5 % in physiological saline for the intradermal induction
40 % in white petrolatum for the epicutaneous induction and
20 % in white petrolatum for the challenge exposure.
Application of Freund's complete adjuvant was included in the intradermal exposure of both groups to enhance a possible sensitisation.
Result: 19/20 animals of the test substance group, i.e. 95 % of the animals, were regarded as sensitised. None in the negative control group.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)